| P2093 | author name string | Kapil Bhalla | |
| | Jason Gotlib | |
| | Celalettin Ustun | |
| | Tracy I George | |
| | Natasha M Savage | |
| | Elizabeth Manaloor | |
| P2860 | cites work | CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy | Q28184867 |
| | Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors | Q33384073 |
| | Plasmacytoid dendritic cell nodules in bone marrow biopsies of chronic myelomonocytic leukemia | Q33392048 |
| | Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder | Q33784323 |
| | Clinical and biologic diversity of leukemias occurring in patients with mastocytosis. | Q34066643 |
| | Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis. | Q34580204 |
| | Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells | Q34658607 |
| | An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL). | Q35769811 |
| | Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. | Q35829710 |
| | Mastocytosis: advances in diagnosis and treatment. | Q36839953 |
| | Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge | Q37775581 |
| | Tyrosine kinase inhibitors in the treatment of systemic mastocytosis. | Q37884959 |
| | Effects of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, on human mast cells bearing wild-type or mutated codon 816 c-kit | Q40263124 |
| | KIT(D816V+) systemic mastocytosis associated with KIT(D816V+) acute erythroid leukaemia: first case report with molecular evidence for same progenitor cell derivation | Q43281205 |
| | Systemic mastocytosis in adults: 2011 update on diagnosis, risk stratification, and management | Q45058347 |
| | Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V. | Q46262657 |
| | Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone | Q47592508 |
| | Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders | Q47709022 |
| | Increased incidence of monoclonal B-cell infiltrate in chronic myeloproliferative disorders. | Q54709754 |
| P433 | issue | 2 | |
| P921 | main subject | mast cell | Q191989 |
| | systemic mastocytosis | Q3851644 |
| P1104 | number of pages | 3 | |
| P304 | page(s) | 191-193 | |
| P577 | publication date | 2011-11-12 | |
| P1433 | published in | American Journal of Hematology | Q4744246 |
| P1476 | title | Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: a case review | |
| P478 | volume | 87 | |